Participants 64 112 4
the LIPID Trial for Secondary Prevention of IHD.
Participants 181 488 8
The Long-term Intervention with Pravastatin in Ischemic Heart Disease (LIPID) trial is a double-blind, randomized, placebo-controlled trial evaluating the long-term effect of pravastatin on coronary mortality in patients with a previous myocardial infarction or unstable angina-ischemic heart disease (IHD).
Participants 489 598 6
It is planned to run for at least five years with 9014 patients from 85 centers in Australia and New Zealand.
